×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
CLASSIFICATION OF MEDICINAL PRODUCTS - FACTORS AFFECTING REGULATORS DECISIONS, IS HARMONISATION POSSIBLE AND NECESSARY?
Session Chair(s)
Hubertus Cranz, PharmD, MBA
Director-General
AESGP, Belgium
The session will look into the change of legal status from prescription to non-prescription by paying particular attention to the challenges for a successful application of the centralised, decentralised or mutual recognition procedures.
Speaker(s)
Moving Emergency Contraception to Non-Prescription Status
Helene Guillard, PharmD
Laboratoire HRA Pharma, France
Director Self-Care Medicines
How to Make the Centralised System Work Better for Non-Prescription Medicines
Mark Griffiths
Pfizer Consumer Healthcare, United Kingdom
Senior Director
Panel Discussion
Tomas Salmonson, DrMed, PhD
Critical Path Institute, United States
Partner
Panel Discussion
Viola Macolic Sarinic, DrSc, MD, MSc
European Medicines Agency, Netherlands
PRAC Scientific Lead
Have an account?